Airbnb Announces New Funding Model for Airbnb.org
Airbnb has introduced a new funding mechanism where a portion of revenue from every booking will support its nonprofit arm, Airbnb.org, aiming to provide $500 million in funding over five years.
Stocks · News reference
This Hewlett Packard Enterprise Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday
Analysts upgraded HPE, Abbott, Airbnb, Horizon Bancorp and Triumph Financial, raising or setting price targets and issuing more bullish ratings.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Airbnb Supports Playing for Keeps Foundation Initiative
Airbnb has provided funding to the Playing for Keeps Foundation to support the development of quality play spaces in underserved communities.
Oppenheimer Adjusts Airbnb Price Target to $210 From $190
Oppenheimer has raised its price target for Airbnb, Inc. from $190 to $210 while maintaining an Outperform rating.
Airbnb vs. Five Below: Which Consumer Stock Is a Better Buy in 2026?
Airbnb and Five Below represent two distinct consumer growth plays with different strengths. Airbnb leads in growth (24.2% avg YoY since 2021) and profitability (19.4% operating margin), while Five Below offers better valuation multiples (P/E 22.0x vs 33.1x) and impressive 22.9% FY2025 revenue growth. The choice depends on whether investors prioritize growth and profitability or value and affordability.
Stock Market Today, Oct. 28: Boston Scientific Slips 6% After Cutting Q4 Sales and Full-Year EPS Guidance on Cyberattack Impact
Boston Scientific (BSX) stock fell 6% after the medical device maker cut its Q4 sales and full-year EPS guidance due to ongoing disruptions from an August cyberattack. The company estimated the eight-day cyberattack cost it 300 basis points in sales growth and $0.07 in adjusted EPS. Management expects a slow recovery with 2027 projected as the trough year, though the stock now trades at a relatively low 13x forward earnings multiple.
Abbott Receives FDA Approval For First And Only Device In The U.S. To Treat Leaks After Heart Valve Replacement Without Additional Surgery